ANG and non-Hodgkin lymphoma: However, patients with hepatocellular cancer (HCC) (p = 0 249), breast cancer (p = 0.443), non-Hodgkin lymphomas (NHLs) (p = 0.257), and melanoma (p = 0.550) did not have significantly higher serum ANG levels than healthy controls.